Structured evidence table for Lactobacillus Rhamnosus Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactobacillus Rhamnosus Gut Health Randomized Trial | Functionally, ScEV-LrEVs showed enhanced anti-inflammatory activity in LPS-stimulated macrophages, accompanied by improved lysosomal function and coordinated changes in mTOR-TFEB-related lysosome-autophagy markers. | 4 | Ji Z (2026) | Fungal extracellular vesicles reshape <i>Lactobacillus rhamnosus</i> vesicles to enhance lysosomal homeostasis and resolve intestinal inflammation. |
| Lactobacillus Rhamnosus Gut Health Randomized Trial | In a DSS-induced colitis model, ScEV-LrEVs alleviated mucosal injury, reduced immune-cell infiltration, and reinforced epithelial barrier integrity, accompanied by restoration of lysosomal function and coordinated changes in mTOR-TFEB-related markers. | 4 | Ji Z (2026) | Fungal extracellular vesicles reshape <i>Lactobacillus rhamnosus</i> vesicles to enhance lysosomal homeostasis and resolve intestinal inflammation. |
| Lactobacillus Rhamnosus Gut Health Randomized Trial | Extracellular vesicles (EVs) are emerging mediators of intercellular and interkingdom communication. | 4 | Ji Z (2026) | Fungal extracellular vesicles reshape <i>Lactobacillus rhamnosus</i> vesicles to enhance lysosomal homeostasis and resolve intestinal inflammation. |
| Lactobacillus Rhamnosus Gut Health Randomized Trial | While bacterial EVs directly modulate host health, whether exogenous vesicles can reprogram gut microbial vesiculation and bioactivity remains unclear. | 4 | Ji Z (2026) | Fungal extracellular vesicles reshape <i>Lactobacillus rhamnosus</i> vesicles to enhance lysosomal homeostasis and resolve intestinal inflammation. |
| Lactobacillus Rhamnosus Gut Health Randomized Trial | Probiotics are living microorganisms that improve overall human health by modulating the gut microbiota and enhancing absorption of nutrients and host immunity. | 4 | Inamdar A (2026) | Unveiling the probiotic potential of <i>L. rhamnosus</i> strain 044AE by genomic and phenotypic characterization. |
| Lactobacillus Rhamnosus Gut Health Randomized Trial | Due to the growing demand for probiotics, efforts are being made to search for and characterize new probiotics. | 4 | Inamdar A (2026) | Unveiling the probiotic potential of <i>L. rhamnosus</i> strain 044AE by genomic and phenotypic characterization. |
Source documents